 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Aclaris Therapeutics Inc. (ACRS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-21 Sale | 2019-06-25 6:31 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 454,261 | $4.5904 | $2,085,238 | 3,751,318 (Indirect) | View |
| 2019-06-26 Sale | 2019-06-26 5:52 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1,704 | $4.5015 | $7,671 | 3,749,966 (Indirect) | View |
| 2019-06-27 Sale | 2019-07-01 5:01 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 699,475 | $2.6907 | $1,882,077 | 3,159,165 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-07-02 Exercise | 2019-07-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 6,000 | $0 | 18,000 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 1,648 | $2.34 | 18,000 (Direct) | View |
| 2019-07-02 Exercise | 2019-07-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 6,000 | $0 | 18,000 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 4:47 pm | N/A 2029-07-01 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 16,000 | $2.34 | 16,000 (Direct) | View |
| 2019-10-30 Option Award | 2019-10-31 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:00 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,733 | $0 | 1,734 (Direct) | View |
| 2019-12-16 Tax Withholding | 2019-12-18 11:00 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 497 | $1.8 | 1,734 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:00 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,733 | $0 | 1,734 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:02 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,300 | $0 | 1,300 (Direct) | View |
| 2019-12-16 Tax Withholding | 2019-12-18 11:02 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 370 | $1.8 | 1,300 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:02 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,300 | $0 | 1,300 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:04 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,033 | $0 | 3,034 (Direct) | View |
| 2019-12-16 Tax Withholding | 2019-12-18 11:04 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 782 | $1.8 | 3,034 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:04 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,033 | $0 | 3,034 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:17 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,075 | $0 | 0 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 4:17 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 277 | $1.81 | 0 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:17 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,075 | $0 | 0 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,250 | $0 | 0 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 356 | $1.81 | 0 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,250 | $0 | 0 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:19 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 2,925 | $0 | 0 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 4:19 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 743 | $1.81 | 0 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:19 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 2,925 | $0 | 0 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:39 pm | N/A 2030-01-06 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 22,000 | $1.85 | 22,000 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 3,875 | $0 | 7,750 (Direct) | View |
| 2020-02-03 Tax Withholding | 2020-02-04 7:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,318 | $1.28 | 7,750 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 3,875 | $0 | 7,750 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 3,875 | $0 | 7,750 (Direct) | View |
| 2020-02-03 Tax Withholding | 2020-02-04 7:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,308 | $1.28 | 7,750 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 3,875 | $0 | 7,750 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:13 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 10,800 | $0 | 21,600 (Direct) | View |
| 2020-02-03 Tax Withholding | 2020-02-04 7:13 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,675 | $1.28 | 21,600 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:13 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 10,800 | $0 | 21,600 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 20,600 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 5,512 | $1.26 | 33,189 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 20,600 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:20 pm | N/A 2030-03-01 | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 116,160 | $1.26 | 33,189 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 33,189 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 17,175 | $0 | 26,551 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 4,779 | $1.26 | 26,551 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 17,175 | $0 | 26,551 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:22 pm | N/A 2030-03-01 | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 92,928 | $1.26 | 26,551 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 66,377 | $0 | 26,551 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 26,551 | $0 | 26,551 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,438 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,438 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,438 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 8,876 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 25,750 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 7,162 | $1.26 | 33,189 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 25,750 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A 2030-03-01 | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 116,160 | $1.26 | 33,189 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 66,377 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 33,189 | $0 | 33,189 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 96,150 | $0 | 0 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 27,623 | $1.26 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 52,564 | $0 | 0 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 15,101 | $1.26 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 96,150 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A 2030-03-01 | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 255,552 | $1.26 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 146,029 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 73,015 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 52,564 | $0 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 52,564 | $0 | 0 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:42 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 33,188 | $0 | 33,189 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 4:42 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 9,534 | $1.32 | 33,189 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:42 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 33,188 | $0 | 33,189 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:43 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 87,500 | $0 | 87,500 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 4:43 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 24,045 | $1.32 | 87,500 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:43 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 87,500 | $0 | 87,500 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 33,188 | $0 | 33,189 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 9,451 | $1.32 | 33,189 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 33,188 | $0 | 33,189 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 73,014 | $0 | 73,015 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 20,976 | $1.32 | 73,015 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 73,014 | $0 | 73,015 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:24 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 16,500 | $1.41 | 16,500 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:27 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 16,500 | $1.41 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:28 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 16,500 | $1.41 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:29 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 16,500 | $1.41 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:30 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 16,500 | $1.41 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:31 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 16,500 | $1.41 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:45 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 16,500 | $1.41 | 16,500 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:46 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:46 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 16,500 | $1.41 | 0 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 5:46 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 7,333 | $0 | 0 (Direct) | View |
| 2020-07-02 Exercise | 2020-07-07 7:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 6,000 | $0 | 12,000 (Direct) | View |
| 2020-07-02 Tax Withholding | 2020-07-07 7:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 1,360 | $1.5 | 12,000 (Direct) | View |
| 2020-07-02 Exercise | 2020-07-07 7:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 6,000 | $0 | 12,000 (Direct) | View |